MICB and pancreatic neoplasm: In this study, we demonstrate that the expression of a novel Anti-MICB-CAR in natural killer (NK) cells results in significant in vitro cellular toxicity and in vivo tumor inhibition of PANC-1 human pancreatic cancer cells.